Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Chromocell Therapeutics Corp ( (CHRO) ) just unveiled an update.
Channel Therapeutics Corporation, formerly Chromocell Therapeutics, has rebranded and reincorporated to emphasize its focus on non-opioid pain treatments using sodium channel modulation. The company is advancing its therapeutic programs, including eye pain and depot programs, with efficacy results anticipated soon. This strategic move is aimed at enhancing growth, valuation, and tax benefits.
Find detailed analytics on CHRO stock on TipRanks’ Stock Analysis page.
